Showing results (941-950 of 1,108) with videos related to

Sort By:
Pageof 111
Antioxidants (Basel, Switzerland)|August 29, 2024
A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular ModelsDavid Gómez-Fernández, Ana Romero-González, Juan M Suárez-Rivero, et al.
Breast Cancer Research : BCR|November 12, 2020
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trialMiguel Quintela-Fandino, Esther Holgado, Luis Manso, et al.
Brain and Behavior|November 10, 2021
Search for schizophrenia and bipolar biotypes using functional network propertiesInés Fernández-Linsenbarth, Álvaro Planchuelo-Gómez, Rosa M Beño-Ruiz-de-la-Sierra, et al.
JAMA Psychiatry|April 19, 2023
Interplay of Metabolome and Gut Microbiome in Individuals With Major Depressive Disorder vs Control IndividualsNajaf Amin, Jun Liu, Bruno Bonnechere, et al.
Nature Communications|December 24, 2025
Proteomic signatures of smoking and their associations with risk of incident diseases and mortality in diverse populationsSihao Xiao, Bowen Liu, M Austin Argentieri, et al.
Science Advances|February 19, 2019
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's diseaseNicholas J Ashton, Alejo J Nevado-Holgado, Imelda S Barber, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Cross-Species and Tissue-Agnostic Prediction of Human Cancer Treatment Response using AI-Powered Cellular Morphometric Biomarkers from a Genetically Diverse Erbb2 Mouse ModelManuel J Perez-Baena, Adrian Blanco-Gomez, Alejandro Jimenez-Navas, et al.
Journal of Clinical Medicine|January 11, 2025
Non-Classical Complications of Adult-Onset Still's Disease: A Multicenter Spanish StudyJavier Narváez, Judith Palacios-Olid, María Jesús García de Yebenes, et al.
Nature Medicine|August 8, 2024
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populationsM Austin Argentieri, Sihao Xiao, Derrick Bennett, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2018
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastasesE E Vokes, N Ready, E Felip, et al.
Pageof 111